July 22, 2014 11:51 PM ET


Company Overview of KaloBios Pharmaceuticals, Inc.

Company Overview

KaloBios Pharmaceuticals, Inc., a biopharmaceutical company, primarily develops monoclonal antibody therapeutics for the treatment of respiratory diseases and cancer in the United States. Its product candidates include KB001-A, which is in a Phase II clinical trial for the prevention and treatment of pseudomonas aeruginosa infection in mechanically ventilated and cystic fibrosis patients; KB003 that is in a Phase II clinical trial for the treatment of inflammatory diseases; and KB004, which is in a Phase I clinical trial for the treatment of hematologic malignancies and solid tumors. The company has a collaboration agreement with Sanofi Pasteur S.A. for the development of KB001-A. KaloBios P...

260 East Grand Avenue

South San Francisco, CA 94080

United States

Founded in 2000

31 Employees



Key Executives for KaloBios Pharmaceuticals, Inc.

Chief Executive Officer
Age: 60
Total Annual Compensation: $417.5K
Chief Medical Officer
Age: 56
Total Annual Compensation: $410.0K
Chief Scientific Officer and Executive Vice President of Research & Development
Age: 62
Total Annual Compensation: $287.5K
Compensation as of Fiscal Year 2013.

KaloBios Pharmaceuticals, Inc. Key Developments

KaloBios Pharmaceuticals, Inc.(NasdaqGM:KBIO) dropped from Russell 2000 Index

KaloBios Pharmaceuticals, Inc. will be removed from the Russell 2000 Index.

KaloBios Pharmaceuticals, Inc.(NasdaqGM:KBIO) dropped from Russell 3000 Index

KaloBios Pharmaceuticals, Inc. will be removed from the Russell 3000 Index.

KaloBios Pharmaceuticals, Inc. Approves an Amendment to the Amended and Restated Certificate of Incorporation

KaloBios Pharmaceuticals, Inc. approved an amendment to the company's amended and restated certificate of incorporation to increase the authorized number of shares of common stock from 47,500,000 shares to 85,000,000 shares at its AGM held on June 18, 2014.

Similar Private Companies By Industry

Company Name Region
Palmetto Biomedical, Inc. United States
Editas Medicine Inc. United States
Applied Microarrays, Inc. United States
Amorcyte, LLC. United States
Happy Valley Medical, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KaloBios Pharmaceuticals, Inc., please visit www.kalobios.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.